Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience
|
|
- Asher Patterson
- 6 years ago
- Views:
Transcription
1 Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : : linda.chatwin@ul.com
2 LINDA M CHATWIN, Esq, RAC Biography Ms. Chatwin has been involved with regulated medical products for over 30 years. She understands the global regulatory maze required to bring products to market, through years of watching regulations evolve and change. She holds a Regulatory Affairs Certification and is an attorney in the U.S. She has obtained product approvals for a wide range of products, and remains involved in changing requirements for medical devices worldwide. She has navigated many FDA inspections, and has negotiated favorable outcomes with FDA. Currently, she assists clients with regulatory issues and challenges, including implementation of UDI processes, performing mock audits, in-depth training on regulatory requirements and consulting on quality system development and improvement.
3 Medical Device Single Audit Program (MDSAP) In an effort to address the growing burden on government agencies for resources necessary to ensure continued medical device manufacturer compliance with quality system regulations and standards, the IMDRF established a work group (in 2012) to establish a single, global audit program known as MDSAP as a substitute for Regulatory Authority (RA) inspections. The idea being that qualified Auditing Organizations (AOs) could prepare audit reports accepted by the IMDRF participating RAs as evidence of compliance. NOTE: The MDSAP adds no new standards or regulations. Includes ISO 13485:2016 requirements along with the country specific regulations.
4 History MDSAP Pilot In January 2014, a MDSAP Pilot process was initiated with a number of international regulatory partners. The intent was that: MDSAP-recognized Auditing Organizations (AOs) would conduct a single audit of a medical device manufacturer that would satisfy the relevant requirements of the medical device regulatory authorities (RAs) participating in the pilot program. These partners would accept the MDSAP audit reports as a substitute for routine regulatory inspections. International partners that participated in the MDSAP Pilot included: Therapeutic Goods Administration of Australia (TGA) Brazil s Agência Nacional de Vigilância Sanitária (ANVISA) Health Canada (HC) US Food and Drug Administration (FDA) Official Observers: The World Health Organization (WHO) Prequalification of In Vitro Diagnostics (IVDs) Programme The European Union (EU) Japan s Ministry of Health, Labour and Welfare (MHLW), and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)
5 History Health Canada In December 2015, Health Canada (HC) confirmed their transition plan for the MDSAP. The MDSAP Pilot program was to conclude 31 Dec. 2016, when HC intended to implement MDSAP as the only vehicle for manufacturers to comply with the QMS requirements of the CMDR (MDSAP would thus replace the current CMDCAS program). This implementation will span 2 years, during which HC will accept both CMDCAS and MDSAP certificates, but as of 01 Jan. 2019, only MDSAP certificates will be accepted Note that HC s transition to MDSAP is an attempt to align with the transition period for ISO 13485:2016.
6 History Health Canada (cont d) HC also noted that all CMDCAS-recognized registrars have been given the opportunity to apply to be authorized MDSAP AOs during the Pilot and have stated their intentions to do so. Manufacturers who have a contract with registrars not yet authorized under MDSAP should contact their registrar and inquire about their expected timeline for approval. To facilitate transition, MDSAP audits may take the place of CMDCAS surveillance audits but certification documents will only be issued once all AO certification requirements have been met. Manufacturers who plan to market their devices only in Canada are required to comply with the regulatory requirements set out in the CMDR, but compliance with foreign regulatory requirements will not be enforced. However, the CDMCAS QMS certificate will need to be replaced with an MDSAP certificate, which may require the services of another registrar / AO.
7 History - FDA In December 2015, the US FDA announced that they were terminating the Pilot Program (effective 31 Mar. 2016) and participating in the operational phase of the MDSAP starting on 01 Jan The report contained generally favorable conclusions, however it was noted that only 45 out of a hoped-for 330 MD manufacturers participated According to the FDA, the MDSAP program provides them better assurances than the Pilot because FDA's requirements under 21 CFR 820 or other FDA regulations typically covered during FDA inspections are encompassed within the MDSAP audit model. As a result of the implementation of the MDSAP program, FDA no longer accepted ISO 13485:2003 Voluntary Audit Report Submissions after 31 March 2016, to assist transitioning manufacturers over to MDSAP.
8 Potential Benefits of MDSAP Global: Reduce the overall number of audits or inspections and optimize the time and resources expended on audit activities Enhance confidence in reliability of 3 rd party audits, so that more RAs join MDSAP, and use MDSAP information to limit the need for additional audits. Some RAs will use audit outcomes as an alternative to their own inspections to process applications for MD marketing authorization. Like in any 3 rd party auditing program, the MD manufacturer is free to choose among all authorized AOs. Routine audits are pre-announced and planned. Improve the predictability of audit outcomes through: enhanced auditing organization recognition criteria monitoring of AOs by the participating RAs the use of a standard MDSAP audit model grading of any nonconformity using objective criteria to characterize the finding reporting audit outcomes using a standard template.
9 Potential Benefits of MDSAP Canada Health Canada will operate the current Canadian Medical Devices Conformity Assessment System (CMDCAS) and MDSAP in parallel during the implementation. Health Canada would accept either an MDSAP certificate or a CMDCAS certificate for the purpose of obtaining a new (or maintaining an existing) Class II, III, or IV medical device license, pursuant to section 32 of the Canadian Medical Devices Regulations. Any Canada-specific benefits (compared with CMDCAS)? none that are obvious.
10 Potential Benefits of MDSAP US FDA plans to accept MDSAP reports as a substitute for FDA routine inspections (biennial by policy). MDSAP routine audits are announced, scheduled by the AO with the manufacturer, with a pre-established duration; The FDA will review MDSAP reports with a level of scrutiny commensurate to the significance of audit findings, taking into account the review and follow-up performed by the AO; Firms have 1 month to provide their full response to critical nonconformities (grade 4 and 5) to the AO (as opposed to 15 working days following a FDA inspection); Certification documents issued by the AO will state compliance with applicable US regulations, which may provide a marketing advantage.
11 Guidance International Medical Device Regulators Forum (IMDRF) main MDSAP documents (can link through FDA portal International Programs). Important documents for Manufacturers include: FAQ MDSAP Audit Models (ISO 13485:2016) MDSAP Companion Documents (ISO 13485:2016) Medical Device Regulatory Audit Report template Nonconformity Grading System for Regulatory Purposes and Information Exchange Links to MDSAP members regulations
12 Auditing Organizations (AO) There are 3 categories Application received Authorized to Conduct MDSAP Audits Recognized
13 Process for AOs The Registrar applies to the MDSAP AO Assessment Body for Recognition The Registrar and its auditors get trained and are then capable of conducting audits, but cannot issue MDSAP certificates until they are Recognized. For Recognition: Assessment by Regulators (including off and on-site audits) of the compliance of the prospective AO s management system to all regulatory requirements Regulators will witness audits of clients by the prospective AO to verify their performance. They do not participate in the client audit itself Once the Regulators are satisfied, they will grant recognition and the AO can issue certificates. All 5 jurisdictions need to be covered and a variety of types and risk classes of devices / IVDs
14 MDSAP Auditing Organizations (AOs) Recognized Authorized to Conduct MDSAP Audits Application Received Under Authorization Process BSI Group America Inc. Recognized Intertek BSI Testing Group Services America NA Inc. Inc. TŰV SŰD Intertek America Testing Inc. Services NA Inc. LNE G-MED TŰV SŰD America Inc. DEKRA Certification B.V Authorized to Conduct MDSAP Audits DQS Medzinprodukte DEKRA Certification GmBH B.V DQS Medzinprodukte GmBH SAI Global Cert. LNE Services G-MEDPTY Ltd. SGS United National Kingdom Standards Ltd. Authority of NSF Ireland Health Sciences SAI Global Certification Cert. Services LLC PTY Ltd. (NSAI) UL Medical and Regulatory Services, TŰV Rheinland of North America Inc. SGS United Kingdom Ltd. UL LCC TŰV USA Inc. QMI-SAI Canada TŰV Limited USA Inc. TŰV Rheinland of North America Inc. Lloyd s Registry UL Quality Medical Assurance and Regulatory Inc. Services, UL LCC National Standards Authority of Ireland (NSAI)
15 MDSAP Audit Model The MDSAP Audit process is built on a risk-based approach and encompasses the QMS requirements for MD manufacturers according to (note that these are regulation-based QMS requirements only): ISO 13485:2003/2016 Brazilian Good Manufacturing Practices (RDC ANVISA 16/2013) FDA Quality System Regulation (21 CFR Part 820) With 2 additional elements needed to fulfil specific requirements of the participating MDSAP RAs: Medical Device Adverse Events and Advisory Notice Reporting Device Marketing Authorization and Facility Registration
16 MDSAP Process: Summary The MDSAP Audit Process Companion document is provided as a reference and includes additional detail regarding each audited process as well as guidance for assessing the conformity of each process. Please refer to the companion document as needed to understand and anticipate the requirements and expectations of the AOs. Remember, MDSAP adds no new regulations, however, most companies will need to implement / improve the following to be compliant: Ensure that all applicable regualtory requiements are well-documented, including new, country-specific procedures and country specific reporting and recall requirements, as appropriate; Ensure that risk management is thoroughly addressed throughout the QMS; Ensure that product changes are evalulated for risk as well as regulatory impact and regultory notificaiton, as applicable; Ensure that your product registrations / listing are current and match your commercialized product.
17 Per Health Canada Status of MDSAP Transition: Transition well underway To date, approximately 1,000 facilities have started transition 575 have already undergone first audit
18 HC Con t Generally, broad support for singe audit concept Stakeholders are concerned about increase in audit time and costs Some Canadian distributors are concerned that foreign suppliers will abandon Canadian market because of MDSAP In December, 2017, HC surveyed holders of Class II, III and IV device license 1,455 responded
19 Stakeholder Feedback Results show that 3 out of 4 intend to transition to MDSAP About 12 % undecided Most intend to complete transition in 2018 Some indicated difficulty scheduling MDSAP audit Those not intending to transition was due to sales not justifying expense of MDSAP
20 Health Canada Response HC is activity monitoring the impact of MDSAP transition Working with AOs to identify and mitigate impact of potential auditor shortages Working with MDSAP RA partners to find audit time reductions HC will soon launch a MDSAP website Exploring options to support smaller manufacturers to transition before deadline
21 AO Response AOs are ready HC working with AOs to identify problems with audit scheduling According to HC, majority of AOs do not foresee significant difficulty in meeting transition deadline Most significant challenge is getting manufacturers to schedule MDSAP audit soon enough to complete before transition deadline Currently over 1400 auditors in MDSAP training program Of these, 700 fully qualified
22 Canadian Experience According to AOs we talk to and Emergo clients, many OCA companies (especially smaller) are considering pulling out due to the significant add l costs Since most companies are waiting to the last minute, this is creating a significant pinch point at the end of 2018, esp. when combined with the concurrent ISO upgrade Most AOs are not taking on new clients, so start-ups are being forced to delay market introduction in Canada (or elsewhere where ISO registration is a requirement)
23 MEDEC Response Major CA Industry Group sent letter January 9, 2018 Concern about challenges of keeping up with requirements around unannounced audits, and release of new versions of ISO 9001:2015 and ISO 13485:2016 Registrars are reporting major non-conformances during witness audits by RAs One large AO reports 25-30% of its client base with withdraw products from Canada, representing approx. 150 companies
24 MEDEC Recommendations Consider extending the transition date to at least January 2020, allowing transition to ISO 13485:2016 Extend CMDCAS viability so that certificates do not expire January 1, 2019 Consider a two track or lean system for several years, which would use ISO plus CMDCAS for companies who only want MDSAP for Canada
25 Question & Answers
26 Thank you for your attention.
Medical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) Kimberly A. Trautman Executive Vice President, Medical Device International Services Health Sciences Medical Devices NSF International This document is intended
More information5 Countries. 1 Unified Audit.
5 Countries. 1 Unified Audit. UNDERSTANDING THE MEDICAL DEVICE SINGLE AUDIT PROGRAM (MDSAP) Melodie Kahl, Mike Wolf, and Scott Edwards July 2017 For more information, please contact: USA Office: + 1 877
More informationMedical Device Single Audit Program (MDSAP) Key Points
Medical Device Single Audit Program (MDSAP) Key Points March 2017 Copyright 2016 BSI. All rights reserved. Copyright 2012 BSI. All rights reserved. 1 What is MDSAP? How does MDSAP work? How does MDSAP
More informationMedical Device Single Audit Program (MDSAP) Copyright 2014 BSI. All rights reserved.
Medical Device Single Audit Program (MDSAP) International Medical Device Regulatory Forum (IMDRF) IMDRF Management Committee (MC) regulators: Australia, Brazil, Canada, China, the European Union, Japan
More informationMedical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) Paul Brooks Senior Vice President BSI Healthcare Solutions Copyright 2015 BSI. All rights reserved. 1 Agenda What is MDSAP? How does MDSAP work? I already have
More informationMDSAP Me M dical D e D vice S i S ngle Audit Program
MDSAP Medical Device Single Audit Program Gary Minks VP, Quality & Regulatory Affairs TÜV SÜD America Inc. gminks@tuvam.com Revision: 2013(09(29 TÜV SÜD America 13(04(29 Slide 1 IMDRF International Medical
More informationMDSAP Overview Marseille,
MDSAP Overview Marseille, 20.10.2017 Sigrid Krimmer-Quendler PhD, MSc EMEA Client Manager MDSAP Support Specialist Copyright 2016 BSI. All rights reserved. 1 Who is this woman?!? Sigrid Krimmer-Quendler
More informationMedical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) October 2017 Roadshow Copyright 2016 BSI. All rights reserved. Copyright 2012 BSI. All rights reserved. 1 How MDSAP works Timelines and Status Auditing Organization
More informationEU Unannounced Audits (UAV) Experience To Date Medical Device Single Audit Program (MDSAP) Copyright 2015 BSI. All rights reserved.
EU Unannounced Audits (UAV) Experience To Date Medical Device Single Audit Program (MDSAP) Copyright 2015 BSI. All rights reserved. Background & Requirements - See Webinars BSI Website Copyright 2015 BSI.
More informationTrial acceptance of MDSAP audit reports in Japan
Trial acceptance of MDSAP audit reports in Japan Pharmaceuticals and Medical Devices Agency (PMDA), Office of Manufacturing / Quality and Compliance March 2018 1 Japan s participation to MDSAP International
More informationMDSAP AUDIT PROCESS. A Manufacturer s Perspective. Connie Hoy EVP Regulatory Affairs Cynosure, Inc.
MDSAP AUDIT PROCESS A Manufacturer s Perspective Connie Hoy EVP Regulatory Affairs Cynosure, Inc. Cynosure Located in Westford, MA Largest manufacturer of Medical Lasers Second location in Hicksville,
More informationIVD Inspections Technical Update Dr Dragana Milic Medical devices inspections
IVD Inspections Technical Update 2018 Dr Dragana Milic Medical devices inspections 1 Objectives Harmonisation - internal and external (PQ Medicines/Vaccines/Vector Control and MDSAP) Transparency (clarify
More informationCANADA (HEALTH CANADA)
1 GMP GAZETTE TM January 2016 HPFBI CANADA (HEALTH CANADA) NNHPD NHPs Notice to Stakeholders Regarding Site Licensing Update Who s affected? Manufacturers, packagers, labellers, importers, and distributors
More informationMedical Device Single Audit Program (MDSAP)
Medical Device Single Audit Program (MDSAP) IMDRF MDSAP International Medical Device Regulators Forum Medical Device Single Audit Program IMDRF recognises that a global approach to auditing and monitoring
More informationDocument issued on: March 19, The draft of this document was issued on May 20, 2010.
Reprinted from FDA s website by Guidance for Industry, Third Parties and Food and Drug Administration Staff Medical Device ISO 13485:2003 Voluntary Audit Report Submission Pilot Program Document issued
More informationMDSAP: CURRENT STATUS AND FUTURE PLANS
MDSAP: CURRENT STATUS AND FUTURE PLANS Seminar hosted by DITTA in conjunction with IMDRF Monday, March 13 2017 Vancouver, BC, Canada A few words about our friend Klaus Stitz: MDSAP: CURRENT STATUS AND
More informationContents. Regulatory Bodies... 13
Contents UNITED STATES... 3 Regulatory Bodies... 3 Product Classification and Regulatory Control... 3 Application Documents... 3 Quality System Requirements... 4 Product and Manufacturer s License... 4
More informationABRIDGED PREQUALIFICATION ASSESSMENT. Prequalification of In Vitro Diagnostics
P r e q u a l i f i c a t i o n T e a m - D i a g n o s t i c s ABRIDGED PREQUALIFICATION ASSESSMENT Prequalification of In Vitro Diagnostics PQDx_173 v3 12 September 2017 (This document version supersedes
More information2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)
WORLD COMPLIANCE SEMINARS SPEAKER:- DAVID R DILLS Regulatory Affairs & Compliance Consultant 2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR) 21-22, FEB- 2018 Burlingame CA Course
More information2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR)
WORLD COMPLIANCE SEMINARS SPEAKER:- DAVID R DILLS Regulatory Affairs & Compliance Consultant 2 DAY WORKSHOP on Preparing For The New EU Medical Device Regulations (MDR) 21-22, FEB- 2018 Burlingame CA Course
More informationMEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155
MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part
More informationHosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil)
Hosting Inspections from foreign countries: PMDA (Japan) ANVISA (Brazil) Kathrin Abelein Vice President Quality, R-Pharm, JSC First Russian GMP Conference 20. 22. September 2016 Agenda General information
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit
More informationAuditing Within the Culture of the Medical Device Industry & ISO 13485:2016 Overview. ASQ Quality Conference 2017 for Region 5 October 25, 2017
Auditing Within the Culture of the Medical Device Industry & ISO 13485:2016 Overview ASQ Quality Conference 2017 for Region 5 October 25, 2017 Introduction / Purpose Discuss the influences of regulatory
More informationCourse Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins
Pre-Clinical Basic Level : CMDA Certified Medical Device Associate Biological Evaluation of Medical Devices: A Risk-Based Approach N134 63 mins 186.00 144.00 Introduction to Process Validation N135 75
More informationDavid W Feigal, Jr., MD MPH
Global Harmonization Summit Where have we been with Harmonization? David W Feigal, Jr., MD MPH Adjunct Professor, College of Law, Arizona State University Partner, NDA Partners LLP September 18, 2014 Washington
More informationThe Third Annual BSI Medical Device Regulatory Road Shows
The Third Annual BSI Medical Device Regulatory Road Shows September 2014 Monday, September 8, 2014 Santa Clara Biltmore Friday, September 12, 2014 Boston Marriott Burlington Wednesday, September 10, 2014
More informationCurrent GMP Inspection of PMDA. Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN
Current GMP Inspection of PMDA Shingou SAKURAI, Ph.D Office of Compliance and Standards Pharmaceuticals and Medical Devices Agency(PMDA), JAPAN GMP Inspection related Organizations in Japan Organizations
More informationCBI s 15 th Annual Product Complaints Congress for Life Sciences
CBI s 15 th Annual Product Complaints Congress for Life Sciences June 14, 2017 Steven Niedelman Lead Quality Systems & Compliance Consultant King & Spalding LLP 1700 Pennsylvania Ave., NW Washington, DC
More informationMedical Device Communiqué
Medical Device Communiqué Q2 2013 Demonstrating the Safety of Medical Devices in the Human Body 1 DOJ: The Focus is on GMPs in 2013 2 ROHS II Impacts Medical Device Companies 3 Demonstrating the Safety
More informationProgress of QMS/QSD WG
4th Joint Conference of Japan and Taiwan Progress of QMS/QSD WG Katsuya SAWADAISHI Office of Manufacturing/Quality and Compliance Division of Medical Devices December 7th, 2016 Main Topics 1. QSD/QMS WG
More informationDiagnostics new product development: overview, WHO s scientific and regulatory role, regulatory pathways and demand creation
Diagnostics new product development: overview, WHO s scientific and regulatory role, regulatory pathways and demand creation Irena Prat Technical Officer, PQDx 1 Global Dx regulatory landscape Dx regulation
More informationComplete global Solutions
Complete global Solutions for ELECtro-Medical devices get your product to market faster we know the way 1 sgs medical network THE As a medical devices manufacturer your focus is to create products that
More informationISO Introduction and Background
ISO 13485 Introduction and Background After more than 10 years, the updated Quality Management standard with the revision of ISO 13485 for the medical device industry is here. The origins of ISO 13485
More informationFINAL DOCUMENT. International Medical Device Regulators Forum. Medical Device Regulatory Audit Reports
FINAL DOCUMENT International Medical Device Regulators Forum Title: Authoring Group: Medical Device Regulatory Audit Reports IMDRF MDSAP Working Group Date: 2 October 2015 Toshiyoshi Tominaga, IMDRF Chair
More informationReport on the Status of UDI in Japan. The Japan Federation of Medical Devices Associations UDI Committee July 3, 2018
Report on the Status of UDI in Japan The Japan Federation of Medical Devices Associations UDI Committee July 3, 2018 1. Developments of UDI in Japan 7/3/2018 3rd Korea-Japan Joint Symposium on Medical
More informationISO 13485:2016 The Final Countdown
ISO 13485:2016 The Final Countdown 03 April 2018 Robert G. Ruff Executive Director, Medical Device Certification and Training 1 This document is intended to facilitate an oral briefing. It is not intended
More informationCDRH s Inspection Strategy for 2018: How it Will Impact Your Company
CDRH s Inspection Strategy for 2018: How it Will Impact Your Company CAPT Sean M. Boyd, MPH, USPHS Deputy Director for Regulatory Affairs CDRH Office of Compliance Patients are at the Heart of What We
More informationAMI MQP Market & Regulatory Analysis. Kyle Cayabyab Jameel Galloway Matt Hammond Meagan Ward
AMI MQP Market & Regulatory Analysis Kyle Cayabyab Jameel Galloway Matt Hammond Meagan Ward Overview Percentage PERCENT ARRHYTHMIA CASES THAT ARE AF 70 60 50 40 30 20 10 0 Percent Arrhythmia Cases that
More informationISO 13485:2016 Medical Devices-Quality Management Systems- Requirements for Regulatory Purposes. Theresa McCarthy
ISO 13485:2016 Medical Devices-Quality Management Systems- Requirements for Regulatory Purposes Theresa McCarthy Welcome and Introductions Please interview and collect: Name Primary Quality Management
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationELECtro-Medical devices. in trusted hands. sgs is the world s leading
ELECTRICAL & ELECTRONICS electro MEDICAL DEVICES ELECtro-Medical devices in trusted hands sgs is the world s leading testing and certification company 1 sgs medical network: THE As a medical devices manufacturer
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationCDRH Pilot Activities
CDRH Pilot Activities Cisco Vicenty Program Manager, Case for Quality 1 Office of Compliance, CDRH November 15, 2017 VCIP Voluntary Compliance Improvement Program Pilot Status Description: Assessment:
More informationFinal Document. 18 September 2014
IMDRFIMDSAP WG/N11FINAL:2014 International Medical Device Regulators Forum Final Document Title: MD SAP Assessment and Decision Process for the Recognition of an Auditing Organization Authoring Group:
More informationIMDRF. Final Document. Regulatory Authority Assessor Competence and Training Requirements. IMDRF MDSAP Work Group
IMDRF/ WG /N6 FINAL:2013 IMDRF International Medical Device Regulators Forum Final Document Title: Authoring Group: Regulatory Authority Assessor Competence and Training Requirements IMDRF MDSAP Work Group
More informationGlobal Medical Device QA/RA Consulting
EmergoGroup.com Global Medical Device QA/RA Consulting More than 2,800 companies trust Emergo to achieve and maintain compliance with global medical device and IVD regulations. Core Areas of Expertise
More informationNOTICE. Re: Guidance Document GD211: Guidance on the Content of Quality Management System audit reports
June 8, 2011 NOTICE Our file number: 11-110913-528 Re: Quality Management System audit reports is pleased to announce the release of the guidance document GD211: Guidance on the Content of. A draft version
More informationMedical Devices Managing Evolving Standards in Multiple Jurisdictions
Medical Devices Managing Evolving Standards in Multiple Jurisdictions Ella Shaw, BSc, Samarind RMS, Application Specialist Dr. Dr. Michel Mikhail, Expert in Global Regulatory Affairs Worldwide Presence
More informationMedical Device Product Innovation
Medical Device Product Innovation Madoka Murakami PMDA, Japan AMDC Industry Training, 3-5 Oct 2017, Surabaya Agenda Introduction of PMDA Medical Device TPLC and Quality Management Typical Nonconformities
More informationUNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD)
UNICEF TECHNICAL REQUIREMENTS FOR MEDICAL DEVICES (MD) A. Background January 2019 UNICEF Technical requirements for Medical Devices are the requirements that suppliers need to comply with, and that products
More informationHow to Get ISO Certified
People frequently ask me where to locate information about ISO 13485, so this whitepaper was written specifically to address their needs, as well as review in detail the six steps to preparing for ISO
More informationDITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM
DITTA CONTRIBUTION TO IMDRF STAKEHOLDER FORUM Satoshi Kimura DITTA Chair JIRA Executive Director IMDRF Stakeholder Forum Tokyo, 25 Mar. 2015 Key Topics Updates about DITTA DITTA views on current work items
More informationPerspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules
Perspective: New European IVD Regulations New Concepts for Market Authorizations and Product Launch Schedules Planning for Efficiencies of Data, Resources, and Timelines A PRECISION BRIEF Introduction
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Overview Global status on MD and IVDs National status on MD and IVDs Legislation Key player and Responsibilities
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8
More informationWHO Prequalification of In Vitro Diagnostics
WHO Prequalification of In Vitro Diagnostics 3 rd WHO Global Forum on Medical Devices Geneva, 10 May 2017 Helena Ardura & Deirdre Healy WHO PQ Team Diagnostics Assessment Essential Medicines and Health
More informationUnannounced Visits. Welcome! We will start the webinar presentation at 9am. Copyright 2014 BSI. All rights reserved.
Unannounced Visits Welcome! We will start the webinar presentation at 9am Copyright 2014 BSI. All rights reserved. Unannounced Visits John Howlett Head of Notified Body Vicky Medley Head of QMS Copyright
More informationYOUR CERTIFICATION PROCESS EXPLAINED
ISO 22000 FOOD SAFETY MANAGEMENT SYSTEMS FSSC 22000 FOOD SAFETY SYSTEM CERTIFICATION This document outlines the audit process for the above referenced standard. It outlines the stages to audit and gives
More informationImplementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan
JCCT workshop on Q8/Q9/Q10 Beijing Implementation of 2005 Pharmaceutical Affairs Law and ICH Q8-Q10 in Japan Yukio HIYAMA Chief, 3 rd Section, Division of Drugs National Institute of Health Sciences, Ministry
More informationPrequalification of in vitro diagnostics - Technical Update 24 November 2015
Prequalification of in vitro diagnostics - Technical Update 24 November 2015 Copenhagen, Denmark 22-26 November 2015 1 Product Dossier Copenhagen, Denmark 22-26 November 2015 2 PQDx Data Quality Expectations
More informationAn EMS is a management tool to improve environmental performance by providing a systematic way of managing an organization s environmental affairs.
ISO 14001 The ISO 14001 standard provides organizations with the framework for an effective environmental management system (EMS) focused on achieving their environmental and economic goals and objectives.
More informationSAI Global Full Service Team
General information regarding elements of the certification process is described below. A degree of flexibility and options in the certification process are available so please feel free to contact us
More informationJapan Update - Implementation of PMD Act - March, 2015
Japan Update - Implementation of PMD Act - March, 2015 Topics Implementation of PMD Act; Revision of Pharmaceutical Affairs Law (PAL) PMDA Medical Device Training Seminar 2 Implementation of PMD Act: The
More informationPROPOSED DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
SG1(PD)/N046R3 PROPOSED DOCUMENT Global Harmonization Task Force Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationAAMI Quality Systems White Paper
AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017, Updated February 2018 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward,
More informationE2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES
E2B(R3): THE INSIDE SCOOP FOR PRODUCT SAFETY TEAMS IN LIFE SCIENCES PREPARING FOR E2B(R3) T he electronic transmission of adverse event information to stakeholders, using the International Conference on
More informationISO 9001:2000 What does it mean in the supply chain?
ISO 9001:2000 What does it mean in the supply chain? What is ISO 9001:2000? ISO 9001:2000 is an international standard that gives requirements for an organization s Quality Management System ( QMS ). It
More informationQMS Aspects of the MDR (& IVDR)
QMS Aspects of the MDR (& IVDR) Vicky Medley Global QMS Manager Medical Devices 27 February 2018 Copyright 2018 BSI. All rights reserved This Presentation 1. The clock is ticking! 2. Dates & priorities
More informationASQ Tappan Zee Section Medical Devices, New Regulations and Standards. 26 th September / V. Fischer / Rev. 01
ASQ Tappan Zee Section Medical Devices, New Regulations and Standards 26 th September / V. Fischer / Rev. 01 Agenda Medical Device, General Aspects Examples Quality System(s) New Regulations & Standards
More informationConduct a More Effective Management Review. Rob Packard, Consultant
Conduct a More Effective Management Review & Slide 1 of 31 Your Speaker Rob Packard Rob Packard is a regulatory consultant with 20 years experience in the medical device, pharmaceutical and biotechnology
More informationUNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS
UNANNOUNCED EU MEDICAL DEVICE AUDITS BY NOTIFIED BODIES: IMPACT ON SUPPLIERS Executive Summary European Medicines Agency (EMA) regulations for licensing of medical devices include the use of authorized
More informationENERGY EFFICIENCY CERTIFICATION. Craig Davenport - Certification Manager Energy Efficiency & Special Programs June 20, 2018
ENERGY EFFICIENCY CERTIFICATION Craig Davenport - Certification Manager Energy Efficiency & Special Programs June 20, 2018 TODAY S AGENDA 01 General Overview of Energy Efficiency North America 02 Regulators,
More informationPublic Consultation on Annual Review and Proposal for Fees For Financial Year Medical Devices
Public Consultation on Annual Review and Proposal for Fees For Financial Year 2018 Medical Devices 8th May 2018 CONTENTS 1 INTRODUCTION 3 2 REVIEW OF THE 2017 FEES 3 2.1 The 2017 fees 3 2.2 The 2018 fees
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More informationUNIQUE DEVICE IDENTIFICATION U.S. FDA. March 2014
UNIQUE DEVICE IDENTIFICATION U.S. FDA March 2014 Introduction The Food and Drug Administration (FDA) has released a final rule requiring most medical devices distributed in the United States to carry a
More informationTABLE OF CONTENTS DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) FREQUENTLY ASKED QUESTIONS JUNE 2015 COMMERCIALIZATION 2 5 REGULATORY 6 9
DUPONT TYVEK MEDICAL PACKAGING TRANSITION PROJECT (MPTP) FREQUENTLY ASKED QUESTIONS TABLE OF CONTENTS COMMERCIALIZATION 2 5 REGULATORY 6 9 TECHNICAL 10 12 BACKGROUND 13 15 For more information, including
More informationFINAL DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
GHTF/SG1/N046:2008 FINAL DOCUMENT Global Harmonization Task Force Title: Principles of Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationJapan Update. IMDRF Open Stakeholder Forum September 2017
Japan Update IMDRF Open Stakeholder Forum September 2017 - Regulatory Authorities in Japan - MHLW Ministry of Health, Labor and Welfare PMDA Pharmaceuticals and Medical Devices Agency Final Authorization
More informationISO and UAV Audits Preparation and Client Rights
1 ISO 13485 and UAV Audits Preparation and Client Rights Medical Devices Quality Management Systems Requirements for Regulatory Purposes 24301 Woodsage Dr. Bonita Springs, FL 34134 (239)-307-6060 www.promedic.cc
More informationOMBU. Ombu Enterprises, LLC Ombu The Operational Excellence Company Ph: Fax: ENTERPRISES, LLC
OMBU ENTERPRISES, LLC Ombu Enterprises, LLC Ombu The Operational Excellence Company Ph: 603-209-0600 Fax: 603-358-3083 OmbuEnterprises@msn.com Docket Number FDA-2010-N-0274 Comments on Oversight of Laboratory
More informationRJ International Limited
RJ International Ltd T/A BIOM NZ ISO 9001:2008 Quality Manual Reference ISO 9001:2008 - Control of Nonconforming Product and Recall Procedure Quality Management System Procedure Subject: Control of Nonconforming
More informationCANADA (HEALTH CANADA)
LEADERS 1 THE GMP GAZETTE TM February 2015 HPFBI CANADA (HEALTH CANADA) Blood Establishment Registration Application: Form and Instructions - (FRM-0353) Who s affected? Anyone who plans to perform the
More informationReview of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices
Review of HPRA Draft Guide to Distribution of Medical Devices, including in vitro diagnostic Medical Devices Ref: IA-G0004-x Summary DCC Vital welcomes the new draft guidance which will provide clarity
More informationISO Client Program and Audit Manual
1 Great Western Registrar LLC ISO Client Program and Audit Manual Based on the requirements of ISO17021 and Associated ANAB Accreditation Rules 04/02/2018 Created and Approved by: Karey S. Yates, President/Owner
More informationAS&D Client Program and Audit Manual
1 Great Western Registrar LLC AS&D Client Program and Audit Manual Based on ISO 17021, AS9104, Associated ANAB Accreditation Rules & ICOP Resolutions 04/02/2018 Created and Approved by: Karey S. Yates,
More informationIndia Authorized Agent Representative for medical device Companies. Responsibilities of the India Authorized Agent representative.
India Authorized Agent Representative for medical device Companies Entellus Food & Drugs Regulatory Services Pvt. Ltd. representing medical device companies with no registered location in India must appoint
More informationOverview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap. Jane Rogers SAAPI Conference 13 April 2016
Overview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap Jane Rogers SAAPI Conference 13 April 2016 Regulatory Framework for Medical Devices & IVDs HAZARDOUS SUBSTANCES
More informationGCP Convergence Improves Transportability of Medical Device Clinical Data
GCP Convergence Improves Transportability of Medical Device Clinical Data By Harmonization-by-Doing Working Group 4 The safety, performance and effectiveness of medical devices are often evaluated by well-controlled
More informationHuman Subject Protection; Acceptance of Data From Clinical Investigations for Medical
This document is scheduled to be published in the Federal Register on 02/21/2018 and available online at https://federalregister.gov/d/2018-03244, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationSPECIAL AUDITS WHAT, WHY AND HOW?
SPECIAL AUDITS WHAT, WHY AND HOW? Mike McRandall and Don McFarland (NSF-ISR) Introductions: Mike McRandall NSF-ISR Business Unit Manager, Aerospace mmcrandall@nsf.org Don McFarland NSF-ISR Technical Scheme
More informationWHO Prequalification of Diagnostics Regulatory
WHO Prequalification of Diagnostics Regulatory Dr Lembit Rägo Head, Regulation of Medicines and other Health Technologies Essential Medicines and Health Products Essential Medicines and Health Products
More informationManaging Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection
Managing Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationQMS regulation in Japan. Office of Manufacturing/Quality and Compliance As of 1st April, 2015
QMS regulation in Japan Office of Manufacturing/Quality and Compliance As of 1st April, 2015 Manufacturing/Quality and Compliance Manufacturing/Quality and Compliance QA of GMP/QMS GMP QMS KANSAI Branch
More informationWHO Update. Mike Ward Department of Essential Medicines and Health Products
WHO Update Mike Ward Department of Essential Medicines and Health Products PQ Statistics WHO PREQUALIFICATION STATISTICS 2015 2016 2017 No of applications 22 65 20 No of new manufacturers 3 5 19 No Prequalified
More informationYour Vision, Our Future Korean Medical Device Your Vision, Our Future
www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at
More informationCOMBINATION PRODUCTS Inspection Readiness and Outcomes
WHITE PAPER COMBINATION PRODUCTS Inspection Readiness and Outcomes Many companies think that because they have a good relationship with the FDA Center they interacted with during their submission reviews
More information